Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2025, 7(2); doi: 10.25236/FMSR.2025.070219.

Mechanisms of kudingcha tea in treating Parkinson's disease: a network pharmacology and molecular docking study

Author(s)

Haiyan Zhu1,2,3, Shenglong Mo2,3, Chongdong Jian2,3

Corresponding Author:
Chongdong Jian
Affiliation(s)

1Graduate School, Youjiang Medical University for Nationalities, Baise, Guangxi, 533000, China

2Department of Neurology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, 533000, China

3Key Laboratory of Prevention and Treatment of High Incidence Diseases in Westrn Guangxi, Guangxi Colleges and Universities, Baise, Guangxi, 533000, China

Abstract

Current PD treatment mainly relies on traditional symptomatic therapy, with new drugs having great potential. Kuding tea, a Chinese medicine with antioxidant properties, might treat PD via antioxidant-driven anti-aging, but its exact mechanism is unclear. This study, combining network pharmacology, differential analysis, PPI network, single-cell analysis, and molecular docking, identified 72 common targets (e.g., CCND1, BCL2L1, PARP1) related to apoptosis, oxidative stress, cell cycle regulation, and the JAK-STAT pathway. Molecular docking confirmed their potential roles, suggesting Kuding tea's components could influence these proteins and pathways, affecting oxidative stress, aging, and inflammation repair in PD treatment, and offering a new research direction for its therapeutic mechanism.

Keywords

Kuding tea; Aging; Parkinson's disease; JAK-STAT pathway

Cite This Paper

Haiyan Zhu, Shenglong Mo, Chongdong Jian. Mechanisms of kudingcha tea in treating Parkinson's disease: a network pharmacology and molecular docking study. Frontiers in Medical Science Research (2025), Vol. 7, Issue 2: 131-137. https://doi.org/10.25236/FMSR.2025.070219.

References

[1] HAYES M T. Parkinson's Disease and Parkinsonism [J]. Am J Med, 2019, 132(7): 802-7.

[2] KALIA L V, LANG A E. Parkinson's disease [J]. Lancet, 2015, 386(9996): 896-912.

[3] LOTANKAR S, PRABHAVALKAR K S, BHATT L K. Biomarkers for Parkinson's Disease: Recent Advancement [J]. Neurosci Bull, 2017, 33(5): 585-97.

[4] FEARNLEY J M, LEES A J. Ageing and Parkinson's disease: substantia nigra regional selectivity [J]. Brain, 1991, 114 ( Pt 5)(2283-301.

[5] REEVE A, SIMCOX E, TURNBULL D. Ageing and Parkinson's disease: why is advancing age the biggest risk factor? [J]. Ageing Res Rev, 2014, 14(100): 19-30.

[6] TRIST B G, HARE D J, DOUBLE K L. Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease [J]. Aging Cell, 2019, 18(6): e13031.

[7] MATTSON M P, ARUMUGAM T V. Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States [J]. Cell Metab, 2018, 27(6): 1176-99.

[8] SONG C, YU Q, LI X, et al. The Hypolipidemic Effect of Total Saponins from Kuding Tea in High-Fat Diet-Induced Hyperlipidemic Mice and Its Composition Characterized by UPLC-QTOF-MS/MS [J]. J Food Sci, 2016, 81(5): H1313-9.

[9] LIU B, MA R, ZHANG J, et al. Preventive Effect of Small-Leaved Kuding Tea (Ligustrum robustum (Roxb.) Bl.) Polyphenols on D-Galactose-Induced Oxidative Stress and Aging in Mice [J]. Evid Based Complement Alternat Med, 2019, 2019(3152324.

[10] XIONG J, LIU X H, BUI V B, et al. Phenolic constituents from the leaves of Cratoxylum formosum ssp. pruniflorum [J]. Fitoterapia, 2014, 94(114-9.

[11] ZHAO X, SONG J L, YI R, et al. Comparison of Antioxidative Effects of Insect Tea and Its Raw Tea (Kuding Tea) Polyphenols in Kunming Mice [J]. Molecules, 2018, 23(1) 

[12] KAKUMU Y, NGUYEN T M T, YAMAUCHI K, et al. New benzoic acid and caffeoyl derivatives with anti-inflammatory activities isolated from leaves of Ilex kaushue [J]. Nat Prod Res, 2022, 36(12): 3013-21.

[13] ZHAO L, ZHANG H, LI N, et al. Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula [J]. J Ethnopharmacol, 2023, 309(116306.

[14] NOOR F, ASIF M, ASHFAQ U A, et al. Machine learning for synergistic network pharmacology: a comprehensive overview [J]. Brief Bioinform, 2023, 24(3) 

[15] ZHANG P, ZHANG D, ZHOU W, et al. Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine [J]. Brief Bioinform, 2023, 25(1) 

[16] KUMAR S, BEHL T, SEHGAL A, et al. Exploring the Role of Orexinergic Neurons in Parkinson's Disease [J]. Neurotox Res, 2021, 39(6): 2141-53.

[17] SALAMA R M, DARWISH S F, YEHIA R, et al. Apilarnil exerts neuroprotective effects and alleviates motor dysfunction by rebalancing M1/M2 microglia polarization, regulating miR-155 and miR-124 expression in a rotenone-induced Parkinson's disease rat model [J]. Int Immunopharmacol, 2024, 137(112536.

[18] CHEN P, ZHANG J, WANG C, et al. The pathogenesis and treatment mechanism of Parkinson's disease from the perspective of traditional Chinese medicine [J]. Phytomedicine, 2022, 100(154044.

[19] WüPPER S, LüERSEN K, RIMBACH G. Chemical Composition, Bioactivity and Safety Aspects of Kuding Tea-From Beverage to Herbal Extract [J]. Nutrients, 2020, 12(9) 

[20] JIANG Z, LU Z, WANG T, et al. Lipid-Lowering Efficacy of Kuding Tea in Patients With Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J]. Front Nutr, 2022, 9(802687.

[21] CHOONG C J, MOCHIZUKI H. Neuropathology of α-synuclein in Parkinson's disease [J]. Neuropathology, 2022, 42(2): 93-103.

[22] SINGH S, JAMWAL S, KUMAR P. Neuroprotective potential of Quercetin in combination with piperine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity [J]. Neural Regen Res, 2017, 12(7): 1137-44.

[23] SONG X, LI C Y, ZENG Y, et al. Immunomodulatory effects of crude phenylethanoid glycosides from Ligustrum purpurascens [J]. J Ethnopharmacol, 2012, 144(3): 584-91.

[24] CHIANG M C, TSAI T Y, WANG C J. The Potential Benefits of Quercetin for Brain Health: A Review of Anti-Inflammatory and Neuroprotective Mechanisms [J]. Int J Mol Sci, 2023, 24(7) 

[25] ACıKARA O B, KARATOPRAK G, YüCEL Ç, et al. A Critical Analysis of Quercetin as the Attractive Target for the Treatment of Parkinson's Disease [J]. CNS Neurol Disord Drug Targets, 2022, 21(9): 795-817.